Results 41 to 50 of about 769,447 (220)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine

open access: yesIndian Journal of Rheumatology, 2023
Cardiac tamponade with systemic lupus erythematosus (SLE) is a rare but fatal complication. Although cardiac tamponade is typically managed with pericardiocentesis and medication, there is no definitive treatment for this condition.
Tomoo Kise   +2 more
doaj   +1 more source

Outcomes of Cardiac Tamponade Post-Transcatheter Aortic Valve Replacement: Results From a Tertiary Cardiac Center

open access: yesStructural Heart
Background: Cardiac tamponade is a rare but potentially lethal complication of transcatheter aortic valve replacement (TAVR). There is paucity of evidence assessing the incidence and outcomes of patients with cardiac tamponade after TAVR.
Simrat Kaur, MD   +14 more
doaj   +1 more source

Unusual cardiac tamponade [PDF]

open access: yesIntensive Care Medicine, 2013
A 69-year-old woman with adult polycystic kidney disease (APCKD) presented herself at our emergency department. A diagnosis of community-acquired pneumonia was made. She was treated with antibiotics, but oxygenation deteriorated quickly and she needed mechanical ventilation.
Joost M R, Meijer, Dylan W, de Lange
openaire   +2 more sources

Infected chylopericardium: An unexpected cause of cardiac tamponade

open access: yes, 2022
A 22-year-old immunocompetent female with a history of small pericardial effusion while infant presented with fever and hemodynamic collapse 4 days after facial trauma.
Skiada, Dimitra   +5 more
core   +1 more source

Covid 19 And Pericarditis: Should We Be Worried About Tamponade?

open access: yes, 2022
INTRODUCTION: Little is known about cardiac manifestations of COVID-19 infection, yet cases of pericarditis, pericardial effusion and with tamponade due to COVID-19 have been reported.
Gul, Muhammad Hamdan   +5 more
core   +1 more source

Low-pressure cardiac tamponade masquerading as severe sepsis diagnosed with a bedside ultrasound and as the initial presentation of malignancy [PDF]

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2014
Objective: We report a patient with low-pressure cardiac tamponade masquerading as sepsis and as the initial presentation of malignancy. A quick diagnosis was done by the intensivist performing a bedside ultrasound.
Ricardo Augusto Slaibi Conti   +1 more
doaj   +1 more source

A Cardiac Tamponade that Does Not Require Pericardiocentesis; a Letter to Editor

open access: yesJournal of Practical Emergency Medicine, 2023
Cardiac tamponade is a leading cause of death in patients with aortic dissection. When aortic dissection is accompanied by cardiac tamponade, emergency surgery to repair the aorta is required.
Alireza Bahmani
doaj   +1 more source

Residual Shunt at 6 Months Follow‐up After Percutaneous Patent Foramen Ovale Closure in CAHAL: A Comparison of Occlutech and Amplatzer

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Residual shunt is a known complication in percutaneous patent foramen ovale (PFO) closure, and moderate to large residual shunt has been associated with an increased risk of recurrent stroke. Device‐related factors, such as device size, have been associated with residual shunt, but comparative data per device type are scarce.
Jelle D. Nieuwendijk   +12 more
wiley   +1 more source

Cardiac arrest following retrieval of inferior vena cava filter: a case report and literature review of pericardial effusion and cardiac tamponade

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2023
This report presents the clinical details and management of a 58-year-old Caucasian male with pericardial effusion and cardiac tamponade following outpatient inferior vena cava (IVC) filter removal.
Fahad Eid   +4 more
doaj   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy